Predictors of Medication-Assisted Treatment Initiation for Opioid Use Disorder in an Interdisciplinary Primary Care Model

References

1. 1.↵
   1. Seth P,
   2. Scholl L,
   3. Rudd RA,
   4. Bacon S

   . Overdose deaths involving opioids, cocaine, and psychostimulants—United States, 2015–2016. MMWR Morb Mortal Wkly Rep 2018;67:349–58.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Murphy SL,
   2. Xu J,
   3. Kochanek KD,
   4. Curtin SC,
   5. Arias E

   . Deaths: Final data for 2015. Natl Vital Stat Rep 2017;66:1–122.

   OpenUrlPubMed
3. 3.↵
   1. Hedegaard H,
   2. Warner M,
   3. Miniño AM

   . Drug overdose deaths in the United States, 1999–2016. NCHS Data Brief 2017;294:1–8.

   OpenUrl
4. 4.↵
   1. Kirson NY,
   2. Scarpati LM,
   3. Enloe CJ,
   4. Dincer AP,
   5. Birnbaum HG,
   6. Mayne TJ

   . The economic burden of opioid abuse: updated findings. J Manag Care Spec Pharm 2017;23:427–45.

   OpenUrl
5. 5.↵
   1. Meyer R,
   2. Patel AM,
   3. Rattana SK,
   4. Quock TP,
   5. Mody SH

   . Prescription opioid abuse: a literature review of the clinical and economic burden in the United States. Popul Health Manag 2014;17:372–87.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Rice JB,
   2. Kirson NY,
   3. Shei A,
   4. et al

   . Estimating the costs of opioid abuse and dependence from an employer perspective: a retrospective analysis using administrative claims data. Appl Health Econ Health Policy 2014;12:435–46.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Thomas CP,
   2. Fullerton CA,
   3. Kim M,
   4. et al

   . Medication-assisted treatment with buprenorphine: assessing the evidence. Psychiatr Serv 2014;65:158–70.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Timko C,
   2. Schultz NR,
   3. Cucciare MA,
   4. Vittorio L,
   5. Garrison-Diehn C

   . Retention in medication-assisted treatment for opiate dependence: a systematic review. J Addict Dis 2016;35:22–35.

   OpenUrl
9. 9.↵
   1. Connery HS

   . Medication-assisted treatment of opioid use disorder: review of the evidence and future directions. Harv Rev Psychiatry 2015;23:63–75.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Mattick RP,
    2. Breen C,
    3. Kimber J,
    4. Davoli M

    . Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2014;2:CD002207.

    OpenUrlPubMed
11. 11.↵
    1. Mitchell SG,
    2. Gryczynski J,
    3. Schwartz RP,
    4. et al

    . Changes in quality of life following buprenorphine treatment: relationship with treatment retention and illicit opioid use. J Psychoactive Drugs 2015;47:149–57.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Vestal C

    . Report from the field: In fighting an opioid epidemic, medication-assisted treatment is effective but underused. Health Aff 2016;35:1052–7.

    OpenUrlFREE Full Text
13. 13.↵
    1. Srivastava A,
    2. Kahan M,
    3. Nader M

    . Primary care management of opioid use disorders. Can Fam Physician 2017;63:200–5.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Rieckmann T,
    2. Muench J,
    3. McBurnie MA,
    4. et al

    . Medication-assisted treatment for substance use disorders within a national community health center research network. Subst Abus 2016;37:625–34.

    OpenUrl
15. 15.↵
    1. Hill RR

    . Medication-assisted treatment should be part of every family physician's practice: no. Ann Fam Med 2017;15:310–2.

    OpenUrlFREE Full Text
16. 16.↵
    1. Rieckmann TR,
    2. Gideonse N,
    3. Risser A,
    4. DeVoe JE,
    5. Abraham AJ

    . Treating opioid dependence with buprenorphine in the safety net: critical learning from clinical data. J Behav Heal Serv Res 2017;44:351–63.

    OpenUrl
17. 17.↵
    1. Lagisetty PA,
    2. Maust D,
    3. Heisler M,
    4. Bohnert A

    . Physical and mental health comorbidities associated with primary care visits for substance use disorders. J Addict Med 2017;11:161–2.

    OpenUrl
18. 18.↵
    Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: Mental Health Findings, NSDUH Series H-49, HHS Publication No. (SMA) 14–4887. Rockville, MD: Substance Abuse and Mental Health Services Administration. Available from: https://www.samhsa.gov/data/sites/default/files/NSDUHmhfr2013/NSDUHmhfr2013.pdf. Published 2014. Accessed January 11, 2019.
19. 19.↵
    1. Lai HMX,
    2. Cleary M,
    3. Sitharthan T,
    4. Hunt GE

    . Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: a systematic review and meta-analysis. Drug Alcohol Depend 2015;154:1–13.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Drake RE,
    2. Essock SM,
    3. Shaner A,
    4. et al

    . Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv 2001;52:469–76.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Lagisetty P,
    2. Klasa K,
    3. Bush C,
    4. Heisler M,
    5. Chopra V,
    6. Bohnert A

    . Primary care models for treating opioid use disorders: what actually works? A systematic review. PLoS One. 2017;12:e0186315.

    OpenUrl
22. 22.↵
    1. Korthuis PT,
    2. McCarty D,
    3. Weimer M,
    4. et al

    . Primary care-based models for the treatment of opioid use disorder: a scoping review. Ann Intern Med 2017;166:268–78.

    OpenUrl
23. 23.↵
    1. Cantone RE,
    2. Fleishman J,
    3. Garvey B,
    4. Gideonse N

    . Interdisciplinary management of opioid use disorder in primary care. Ann Fam Med 2018;16:83.

    OpenUrlFREE Full Text
24. 24.↵
    Mission and History. OCHIN. Available from: https://ochin.org/mission-history/. Accessed November 15, 2018.
25. 25.↵
    Centers for Disease Control and Prevention. 2018 Annual Surveillance Report of Drug-Related Risks and Outcomes—United States. Surveillance Special Report. Hyattsville, MD: Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; 2018. Available from: https://www.cdc.gov/drugoverdose/pdf/pubs/2018-cdc-drug-surveillance-report.pdf
26. 26.↵
    1. Becker WC,
    2. Sullivan LE,
    3. Tetrault JM,
    4. Desai RA,
    5. Fiellin DA

    . Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend 2008;94:38–47.

    OpenUrlCrossRefPubMedWeb of Science